Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico

Friends Research Institute, Inc.360 enrolled

Overview

The purpose of this study is to compare the effectiveness in reducing drug use and its associated problems of a brief intervention for drug use delivered by a behavioral health counselor as compared to a brief intervention delivered by a computerized intervention.

Drug use is a significant cause of morbidity and mortality in the United States. Efforts to develop and rigorously evaluate methods to provide Screening, Brief Intervention and Referral to Treatment (SBIRT) for drug users are needed. Computerized screening and brief interventions in particular have the potential to circumvent some of the potential problems of integrating SBIRT delivered by a counselor into busy primary care settings. These interventions may reduce drug use among individuals who are using drugs but are not yet drug dependent.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

360

Conditions

Drug Abuse HIV Risk Behavior

Interventions

Computerized brief interventionBEHAVIORAL

This is a brief computerized intervention focused on drug use of patients receiving primary care treatment in an outpatient setting. The intervention is delivered in one session.

Counselor delivered brief interventionBEHAVIORAL

This is a one session brief intervention delivered in a primary care setting that is based on motivational interviewing.

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years or older * Moderate risk category on the ASSIST scores Exclusion Criteria: * planning to move out of New Mexico in the next year * receipt of formal drug abuse treatment or a brief intervention for drug use in the past month.

Locations (1)

Friends Research Institute

Baltimore, Maryland, United States

Outcomes

Primary Outcomes

Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score

The ASSIST's Global Continuum of Illicit Drug Risk was used. A higher score is considered more severe risk. The scores range from 0 to 308.

Time frame: 3 months post-baseline

Hair Testing

The number of participants testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC)

Time frame: 3 month post-baseline

Secondary Outcomes

Human Immunodeficiency Virus (HIV) Drug Use Risk Assessment Battery Subscale

HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.

Time frame: 3 months post-baseline

Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score

ASSIST's Global Continuum of Illicit Drug Risk Score which ranges from 0 to 308. A higher score is associated with higher risk.

Time frame: 6 month post-baseline

Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score

ASSIST's Global Continuum of Illicit Drug Risk Score which ranges from 0 to 308. A higher score is associated with higher risk.

Time frame: 12 months post-baseline

Hair Testing

The predicted probabilities for testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC), calculated from generalized estimating equations.

Time frame: 6 month post-baseline

Hair Testing

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.